Aruna Dharshan de Silva

Dr. Aruna Dharshan de Silva

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2018 in Science Immunology
Verified
Journal Article
Closed access
PDF file
VPVeena S. Patil
Veena S. Patil
AMAriel Madrigal
Ariel Madrigal
BSBenjamin J. Schmiedel
Benjamin J. Schmiedel
JCJames Clarke
James Clarke
POPatrick O’rourke
Patrick O’rourke
PVPandurangan Vijayanand
Pandurangan Vijayanand
Human CD4 + cytotoxic T lymphocytes that play a vital role in antiviral immunity are highly heterogeneous.

24 May 2019 in Science Immunology
Verified
Journal Article
Open access
PDF file
NKNurgun Kose
Nurgun Kose
JFJulie Fox
Julie Fox
GSGopal Sapparapu
Gopal Sapparapu
RBRobin Bombardi
Robin Bombardi
RTRashika N. Tennekoon
Rashika N. Tennekoon
JCJames E. Crowe
James E. Crowe
Lipid nanoparticles containing mRNA encoding a human antibody for chikungunya virus protect against infection and arthritis.

5 December 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RRRajendra Raut
Rajendra Raut
KCKizzmekia S. Corbett
Kizzmekia S. Corbett
RTRashika N. Tennekoon
Rashika N. Tennekoon
SPSunil Premawansa
Sunil Premawansa
AWAnanda Wijewickrama
Ananda Wijewickrama
ASAravinda M. de Silva
Aravinda M. de Silva
Significance: Due to difficulty in obtaining relevant samples and low levels of dengue virus (DENV) present in patients, it has been difficult to characterize the properties of virions circulating in humans. We characterized DENV1 directly from early acute primary dengue samples and from their cell culture isolates. We observed that virions in humans are more infectious and mature as compared with their cell culture isolates. DENV1 cell culture isolates were hypersensitive to neutralization by human antibodies. Cross-reactive fusion loop antibodies and heterotypic immune sera poorly neutralized plasma DENV1. Identical genome sequences showed that the phenotypic differences are due to the differences in maturation state. The observed structural variation is a significant advance applicable to understanding vaccine failure and designing future vaccine strategies.

15 December 2018 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
AGAlba Grifoni
Alba Grifoni
PCPriscilla Costa-Ramos
Priscilla Costa-Ramos
JPJohn Pham
John Pham
YTYuan Tian
Yuan Tian
SRSandy L. Rosales
Sandy L. Rosales
Alessandro SetteAlessandro Sette
Alessandro Sette
Zika virus (ZIKV) constitutes an increasing public health problem. Previous studies have shown that CD8+ T cells play an important role in ZIKV-specific protective immunity. We have previously defined antigenic targets of the ZIKV-specific CD8+ T cell response in humans. In this study, we characterized the quality and phenotypes of these responses by a combined use of flow cytometry and transcriptomic methods, using PBMCs from donors deriving from different geographical locations collected in the convalescent phase of infection. We show that ZIKV-specific CD8+ T cells are characterized by a polyfunctional IFN-γ signature with upregulation of TNF-α, TNF receptors, and related activation markers, such as CD69, as well as a cytotoxic signature characterized by strong upregulation of GZMB and CRTAM. The signature is stable and not influenced by previous dengue virus exposure, geographical location, or time of sample collection postinfection. To our knowledge, this work elucidates the first in-depth characterization of human CD8+ T cells responding to ZIKV infection.

1 November 2011 in Emerging Infectious Diseases
Verified
Journal Article
Open access
HTHasitha A Tissera
Hasitha A Tissera
EOEng Eong Ooi
Eng Eong Ooi
DGDuane J Gubler
Duane J Gubler
Ying TanYing Tan
Ying Tan
BLBarathy Logendra
Barathy Logendra
ASAruna Dharshan de Silva
Aruna Dharshan de Silva
The number of cases and severity of disease associated with dengue infection in Sri Lanka has been increasing since 1989, when the first epidemic of dengue hemorrhagic fever was recorded. We identified a new dengue virus 1 strain circulating in Sri Lanka that coincided with the 2009 dengue epidemic.

25 July 2025 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
DLD.A. Lamabadusuriya
D.A. Lamabadusuriya
HJHiruni Jayasena
Hiruni Jayasena
ABA.K. Bopitiya
A.K. Bopitiya
ASAruna Dharshan de Silva
Aruna Dharshan de Silva
PJP. Jayasekera
P. Jayasekera